Abciximab
Welcome to the Abciximab information hub.Scroll down to read supplemental details and discuss this drug.
Abciximab Overview
Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.[1] While Abciximab has a short plasma half-life, due ... Read more Abciximab DetailsDetails May Include Instructions, Side Effects, Interactions, Etc.
Drug monograph is from Wikipedia. All text is available under the terms of the GFDL
(GNU Free Documentation License) | http://en.wikipedia.org/wiki/Abciximab
Recent Abciximab Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Abciximab
- Injection: 2mg/ml
Other drugs which contain Abciximab or a similar ingredient: (1 result)
- ReoPro Abciximab
Possibly related Abciximab Topics:
- reopro (abciximab) for cardiac ischemic complications ReoPro(Abciximab) is a monoclonal antibody that bl...
